Johnson DA - Search Results

1

In vivo antitumor activity of a monoclonal antibody-Vinca alkaloid immunoconjugate directed against a solid tumor membrane antigen characterized by heterogeneous expression and noninternalization of antibody-antigen complexes.

Starling JJ, Maciak RS, Law KL, Hinson NA, Briggs SL, Laguzza BC, Johnson DA. Starling JJ, et al. Among authors: johnson da. Cancer Res. 1991 Jun 1;51(11):2965-72. Cancer Res. 1991. PMID: 2032233

2

Epidermal growth factor receptor-reactive monoclonal antibodies: xenograft antitumor activity alone and as drug immunoconjugates.

Gutowski MC, Briggs SL, Johnson DA. Gutowski MC, et al. Among authors: johnson da. Cancer Res. 1991 Oct 15;51(20):5471-5. Cancer Res. 1991. PMID: 1913667

3

Antitumor activity of L/1C2-4-desacetylvinblastine-3-carboxhydrazide immunoconjugate in xenografts.

Johnson DA, Baker AL, Laguzza BC, Fix DV, Gutowski MC. Johnson DA, et al. Cancer Res. 1990 Mar 15;50(6):1790-4. Cancer Res. 1990. PMID: 2306731

4

New antitumor monoclonal antibody-vinca conjugates LY203725 and related compounds: design, preparation, and representative in vivo activity.

Laguzza BC, Nichols CL, Briggs SL, Cullinan GJ, Johnson DA, Starling JJ, Baker AL, Bumol TF, Corvalan JR. Laguzza BC, et al. Among authors: johnson da. J Med Chem. 1989 Mar;32(3):548-55. doi: 10.1021/jm00123a007. J Med Chem. 1989. PMID: 2783975

5

Tissue distribution and cellular location of the antigens recognized by human monoclonal antibodies 16.88 and 28A32.

Starling JJ, Cote RJ, Marder P, Borowitz MJ, Johnson DA. Starling JJ, et al. Among authors: johnson da. Cancer Res. 1988 Dec 15;48(24 Pt 1):7273-8. Cancer Res. 1988. PMID: 3056612

6

In vivo antitumor activity demonstrated with squamous carcinoma reactive monoclonal antibody-Vinca immunoconjugates.

Johnson DA, Zimmermann JL, Laguzza BC, Eble JN. Johnson DA, et al. Cancer Immunol Immunother. 1988;27(3):241-5. doi: 10.1007/BF00205446. Cancer Immunol Immunother. 1988. PMID: 3180148 Free PMC article.

7

Antitumor xenograft activity with a conjugate of a Vinca derivative and the squamous carcinoma-reactive monoclonal antibody PF1/D.

Johnson DA, Laguzza BC. Johnson DA, et al. Cancer Res. 1987 Jun 15;47(12):3118-22. Cancer Res. 1987. PMID: 3495327

8

Anti-tumor activity of CC49-doxorubicin immunoconjugates.

Johnson DA, Briggs SL, Gutowski MC, Barton R. Johnson DA, et al. Anticancer Res. 1995 Jul-Aug;15(4):1387-93. Anticancer Res. 1995. PMID: 7654026

9

Induction of immunogenicity of monoclonal antibodies by conjugation with drugs.

Johnson DA, Barton RL, Fix DV, Scott WL, Gutowski MC. Johnson DA, et al. Cancer Res. 1991 Oct 15;51(20):5774-6. Cancer Res. 1991. PMID: 1913696

10

Reduction of toxicity of a vinca alkaloid by an anti-vinca alkaloid antibody.

Gutowski MC, Fix DV, Corvalan JR, Johnson DA. Gutowski MC, et al. Among authors: johnson da. Cancer Invest. 1995;13(4):370-4. doi: 10.3109/07357909509031917. Cancer Invest. 1995. PMID: 7627723

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,135 results

Search Page

Filters